US5096898A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Bile acid unsaturated derivatives and pharmaceutical compositions containing them
Assignee: Giuliani SpA
•
Filing: 1991-02-05
•
Granted: 1992-03-17
•
Expires: 2011-02-05
Abstract
Abstract Bile acid derivatives of formula I ##STR1## wherein: R is hydrogen or hydroxy; X is a carboxy or a SO 3 H group, have valuable pharmacologic properties.
Inventors
- 👤 Roberto Pellicciari
- 👤 Aldo Roda
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 12:39
CPC Classifications
C; C07; C07J; C07J31/00; C07J31/006; A; A61; A61P; A61P1/00; A61P1/16; C07J9/00; C07J9/005; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
21 words
Compounds of formula I ##STR5## wherein: R is hydrogen or hydroxy; X is a carboxy or a SO 3 H group.
Claim 2
Dependent Claim
21 words
Compounds of formula I ##STR5## wherein: R is hydrogen or hydroxy; X is a carboxy or a SO 3 H group.
Claim 3
Dependent Claim
10 words
Compounds of formula I wherein X is a carboxy group.
Claim 4
Dependent Claim
10 words
Compounds of formula I wherein X is a carboxy group.
Claim 5
Dependent Claim
18 words
Compounds of claim 1, wherein R is hydroxy and the hydroxy group in 7 is in α configuration.
Claim 6
Dependent Claim
18 words
Compounds of claim 1, wherein R is hydrogen and the hydroxy group in 7 is in α configuration.
Claim 7
Dependent Claim
18 words
Compounds of claim 1, wherein R is hydrogen and the hydroxy group in 7 is in β configuration.
Claim 8
Dependent Claim
18 words
Compounds of claim 1, wherein R is hydroxy and the hydroxy group in 7 is in β configuration.
Claim 9
Dependent Claim
33 words
A pharmaceutical composition having choleretic, anticholestatic and antilithiasis activities which comprises as the principal active ingredient an effective amount of a compound according to claim 1 in admixture with a pharmaceutically acceptable carrier.
Claim 10
Dependent Claim
22 words
A method of treating cholestatic syndromes which comprises administering to a patient an effective amount of a compound according to claim 7.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-03-17 | 1995-09-16 | 1996-03-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-03-17 | 1999-09-16 | 2000-03-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-03-17 | 2003-09-16 | 2004-03-17 | $7700.00 | Window Closed / Lapsed |